Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Summit Therapeu ADR (SMMT)

Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,178,196
  • Shares Outstanding, K 737,448
  • Annual Sales, $ 0 K
  • Annual Income, $ -614,930 K
  • EBIT $ -197 M
  • EBITDA $ -195 M
  • 60-Month Beta -0.92
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 30.99

Options Overview Details

View History
  • Implied Volatility 85.70% ( +6.31%)
  • Historical Volatility 64.04%
  • IV Percentile 8%
  • IV Rank 17.24%
  • IV High 283.55% on 02/09/24
  • IV Low 44.48% on 01/10/24
  • Put/Call Vol Ratio 0.21
  • Today's Volume 1,546
  • Volume Avg (30-Day) 1,801
  • Put/Call OI Ratio 0.89
  • Today's Open Interest 82,230
  • Open Int (30-Day) 78,001

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.08
  • Number of Estimates 3
  • High Estimate -0.07
  • Low Estimate -0.09
  • Prior Year -0.05
  • Growth Rate Est. (year over year) -60.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.52 +9.56%
on 12/03/24
19.54 -7.37%
on 11/26/24
-0.90 (-4.74%)
since 11/22/24
3-Month
16.52 +9.56%
on 12/03/24
24.84 -27.13%
on 09/25/24
-3.81 (-17.39%)
since 09/23/24
52-Week
2.10 +761.90%
on 05/28/24
33.89 -46.59%
on 09/16/24
+15.73 (+663.71%)
since 12/22/23

Most Recent Stories

More News
Where Will Summit Therapeutics Be in 5 Years?

Summit Therapeutics (NASDAQ: SMMT) has risen in prominence in the past two years thanks to a promising pipeline candidate, ivonescimab, a potential cancer treatment. The company's shares are up by 340%...

SMMT : 18.10 (+1.29%)
3 Stocks That Could Turn $1,000 into $5,000 by 2030

A five-bagger in only five years? Any investor would love to buy such a stock. Fortunes can be made quickly with those kinds of turbocharged performers.

GOOGL : 192.60 (+0.62%)
GOOG : 193.93 (+0.50%)
TSLA : 430.00 (+2.12%)
MRK : 98.10 (+0.05%)
SMMT : 18.10 (+1.29%)
WRD : 14.89 (+1.29%)
MRNA : 39.66 (+0.69%)
UBER : 61.05 (+0.53%)
3 No-Brainer Biotech Stocks to Buy With $200 Right Now

Investing in biotech stocks usually isn't for the faint of heart. These stocks tend to be highly volatile because of the inherent risks of developing new drugs.

SMMT : 18.10 (+1.29%)
MRNA : 39.66 (+0.69%)
BNTX : 112.35 (-0.65%)
2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street

It's been a good year for the stock market as a whole and a tremendous year for a couple of drugmaker start-ups. Shares of Viking Therapeutics (NASDAQ: VKTX) and Summit Therapeutics (NASDAQ: SMMT) more...

VKTX : 43.15 (+2.13%)
WFC : 70.12 (-0.31%)
SMMT : 18.10 (+1.29%)
LLY : 782.50 (+1.92%)
Investing $5,000 in Each of These 3 Stocks at the Start of 2024 Would Have Created a Portfolio Worth More Than $100,000 Today

Normally, you might expect to achieve significant gains from stocks if you invest in them for years, perhaps decades. But given how hot the stock market has been this year, some stocks have produced life-changing...

MSTR : 357.30 (-1.89%)
APP : 345.60 (+1.35%)
NVDA : 135.72 (+0.76%)
SMMT : 18.10 (+1.29%)
Why Summit Therapeutics Stock Rocketed 6% Higher on Friday

Summit Therapeutics (NASDAQ: SMMT) stock got a real shot in the arm Friday with the initiation of coverage by a veteran financial services company. On news that Jefferies is now tracking the stock, investors...

SMMT : 18.10 (+1.29%)
MRK : 98.10 (+0.05%)
JEF : 76.50 (+0.37%)
Billionaire Ken Griffin Is Selling Palantir and Buying a Stock Wall Street Expects to Rocket 139% Higher

Do you ever wonder what America's wealthiest stock traders are buying and selling? Thanks to the Securities and Exchange Commission, you don't have to. Every three months, anyone with over $100 million...

SMMT : 18.10 (+1.29%)
PLTR : 81.05 (+0.62%)
Warning: This Skyrocketing Stock Has a Hidden Risk

Up 860% in the last 12 months alone, Summit Therapeutics (NASDAQ: SMMT) is a skyrocketing stock that likely has more upside in store.

SMMT : 18.10 (+1.29%)
3 Monster Stocks in the Making

Godzilla and King Kong surely weren't born big. They began small and grew over time to their gargantuan sizes even if the movies don't tell their childhood stories.

VKTX : 43.15 (+2.13%)
CRSP : 40.90 (+0.44%)
SMMT : 18.10 (+1.29%)
MarketBeat Week in Review – 11/4 - 11/8

Markets rallied strongly this week on clarity about the election and an expected rate cut, but next week's inflation readings will determine if momentum lasts

NVDA : 135.72 (+0.76%)
SMMT : 18.10 (+1.29%)
MRK : 98.10 (+0.05%)
ALT : 8.45 (+2.42%)
ENVX : 9.81 (+0.82%)
CCL : 26.69 (-0.41%)
COIN : 274.16 (-1.63%)
BMY : 57.55 (+0.38%)
FSLR : 182.51 (+0.07%)
SOUN : 22.75 (+4.57%)
QCOM : 156.00 (+2.03%)
INTC : 19.57 (+0.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Summit Therapeutics PLC is engaged in the discovery and development of drug to treat the fatal muscle wasting disease Duchenne Muscular Dystrophy and infections caused by the bacteria C. difficile. Summit Therapeutics PLC is headquartered in Abingdon, the United Kingdom.

See More

Key Turning Points

3rd Resistance Point 19.30
2nd Resistance Point 18.95
1st Resistance Point 18.41
Last Price 18.10
1st Support Level 17.52
2nd Support Level 17.17
3rd Support Level 16.63

See More

52-Week High 33.89
Fibonacci 61.8% 21.75
Last Price 18.10
Fibonacci 50% 17.99
Fibonacci 38.2% 14.24
52-Week Low 2.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar